Curious about our podcast secrets?

Subscribe to our Newsletter and connect on Facebook!
Click here to get the inside scoop—delivered weekly.

Medscape InDiscussion: Systemic Lupus Erythematosus

Medscape InDiscussion: Systemic Lupus Erythematosus

Medscape InDiscussion: Systemic Lupus Erythematosus

We estimate there's a 100% chance this podcast is looking for guests- reach out and make your move!

Topic Category:

Science, Health and Fitness

Topic Sub-Category:

Medicine

(Log in to see email address)

Language:

English

Podcast Stats:

Number of Episodes: 2
Series Type: episodic
Content Type: AUDIO

Podcast Description

Listen to Medscape InDiscussion: Systemic Lupus Erythematosus, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002123. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Podcast Insights

Content Themes

Centers on the latest research and clinical guidelines regarding lupus, with specific episodes covering the new KDIGO, ACR, and EULAR guidelines for lupus nephritis, and lupus epidemiology data emphasizing the importance of understanding disease prevalence for frontline physicians.

Further Podcast insights, such as show format, guest types, ideal guests, and target audience are available to Podcast Collab Club Members!

Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.

 

For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.